Chamber and committees

Curriculum for Excellence (CfE) is non-prescriptive in nature, allowing teachers and schools to judge the context for learning that best suits their learners and their individual circumstances. Therefore decisions about which pedagogies to use are for schools and local authorities to determine, in line with CfE.

Although we do not collect the specific data requested, play pedagogy is encouraged and utilised to support the social, emotional, physical and cognitive development of young children in a developmentally appropriate way at the early level of Curriculum for Excellence, from early learning and childcare(ELC) and into the early stages of Scotland’s primary schools.

In 2020 the Scottish Government and Education Scotland published ‘Realising the Ambition: Being Me – Practice Guidance for the Early Years in Scotland’. This guidance for practitioners in early learning and childcare and the early years of primary school updates, extends and strengthens the approaches to active learning and play introduced in ‘Building the Curriculum 2’ (2007). ‘Realising the Ambition’ reflects current evidence and the progress made in understanding how best to support learning and care for children in their early years.

In July 2022 Education Scotland updated the online Early Level Play Pedagogy Toolkit. The toolkit was co-produced with Scottish practitioners and complements the quality improvement support Education Scotland is providing in collaboration with Regional Improvement Collaboratives and local authorities. The toolkit aims to support a deeper understanding of play pedagogy and increase the confidence of early level practitioners (including those in schools) in using play effectively to support children’s learning and development.

The Scottish Government and Public Health Scotland (PHS) are working together with Health Boards to support their planning and the safe delivery of monkeypox vaccination to support the response to the current outbreak.

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended offering the vaccine to people who are at higher risk of coming into contact with monkeypox to help reduce the spread.

There is currently a limited global supply of existing MVA vaccine which Scotland has secured its share of. Vaccination is underway and it is currently being offered to those at highest risk first.

Additional supplies are expected in September, and people will be offered a first dose in priority order as soon as it becomes available.

The Scottish Government does not consider setting a nationwide target for sustainable deer populations to be the most effective method of meeting our Biodiversity Strategy targets for 2030. Our approach is to assess and identify priority areas where there is evidence of, or a high risk of deer damage, to ensure deer management efforts are focused and coordinated where there is the greatest need.

We set out our commitment to modernising Scotland's systems of deer management in response to the independent Deer Working Group and work is being taken forward as part of our new deer project. This project sits under the Scottish Biodiversity Strategy Programme Board and work is being taken forward via four workstreams focusing on: legislation; regulation; incentives; and operational delivery.

Procurement of the MVA vaccine is being managed by UK Health Security Agency (UKHSA) on a 4 nations basis. Scotland has secured a limited supply of 3,000 doses so far and will have access to more stock once it becomes available.

UKSHA have procured a further 100,000 vaccines that will be arriving in September. Date of arrival and details on Scotland’s share are still to be confirmed.

The Scottish Government is committed to early diagnosis which is why we continue to invest in our £44 million Detect Cancer Early (DCE) Programme. In 2021-22, DCE funded the North Cancer Alliance to support community pharmacy in the identification of patients with symptoms suspicious of cancer and, where necessary, prompt referral to an urgent suspicion of cancer (USC) pathway.

Learnings from this early work will be shared with the Early Cancer Diagnosis Programme Board and help inform possible wider roll-out across NHS Scotland.

A new early cancer diagnosis vision is under development as part of Scotland’s new cancer strategy, due to be published Spring 2023, and will consider the role of community pharmacies in supporting earlier diagnosis efforts.

The National Mission has been set out for the five years of this Parliament and with it comes a commitment to fund the MAT standards. I have previously given Parliament and delivery partners assurance that funding is to be used for Alcohol and Drugs Partnerships and front-line services to support local areas in meeting the MAT standards. Initial funding of £6 million was provided to Health Boards on 1 March 2022 following discussions with Integration Authorities on the appropriate amount required to deliver the initial set of objectives.

Funding requirements for meeting the MAT standards for 2022/2023 and beyond was agreed with ADPs between January and April 2022 as being over £10 million per year for the next 4 years, to supplement the initial £6 million. The formal notification letter for 2022-23 was sent out to Integration Authorities and Health Boards in June 2022. Health Boards will draw down additional funding for 2022-23 as and when the initial funding has been utilised.

There are a number of routes that developers of a new medical device may follow, in order to pursue NHSScotland approval. As a test for early cancer detection, Trucheck would fall within the remit of the Scottish Health Technologies Group (SHTG), which is a national Heath Technology Assessment (HTA) agency based within Healthcare Improvement Scotland. SHTG advice is developed following a request for evidence support on issues facing health and social care services. The SHTG has not provided advice on the use of Trucheck to date.

Scottish Government have just released in Beta form, Scotland Innovates ( www.innovator.scot). Scotland Innovates allows suppliers and citizens to submit proposals to the entire public sector in Scotland that could potentially create innovate goods and services and bring benefit to our citizens. Advice is available on the site regarding the possible submission of a proposal.

The medicines and Healthcare products Regulatory Agency (MHRA) regulates medical devices in the UK, we recommend that medical devices are registered with MHRA prior to placing the device on the UK market.

I understand that the UK Government’s e-scooter trials, which commenced in July 2020, are still ongoing in England. The first phase of analysis of the trials is now complete, and I understand that this will be published in autumn 2022.

Transport Scotland has still not received any data or analysis from the trials in England from the UK Government. My officials will continue to push for sight of this data.

The Scottish Government is currently consulting on its final proposals for the New Build Heat Standard. This consultation will inform the final regulations which are expected to be laid during 2023 before coming into force in April 2024. Alongside those regulations we will publish a Business Regulatory Impact Assessment. This will set out estimated costs and benefits of the approach, including emissions reductions.

The answer to your question is outlined in the following tables. Please note, data for 2021-2022 Area Based Schemes are still being collected and will be published on the ABS webpage in due course: Area Based Schemes: annual final measures reports - gov.scot (www.gov.scot) .

“Zero Carbon” heating for the purposes of this response is defined as heating which does not generate carbon emissions at the point of use. Solar and battery storage are not counted towards the Zero Carbon figure as they are usually installed in conjunction with other microgeneration measures, for example air source heat pumps.

Warmer Homes Scotland